Literature DB >> 19952698

Flap monitoring and patient management.

Christopher J Salgado1, Steven L Moran, Samir Mardini.   

Abstract

Complications in free-tissue transfer patients cannot be completely prevented; however, the incidence may be significantly reduced by a thorough preoperative evaluation and initiation of prophylactic strategies, meticulous surgical technique, and diligent postoperative monitoring. Emergent exploration must be performed soon after obstruction occurs if it is to be successful, and early exploration and repair is likely in compromised flaps if they are monitored frequently in the initial postoperative period. This article reviews the importance of clinical management in this patient population, the recommended frequency of flap monitoring, and the most commonly used methods of monitoring the transferred tissue whether or not the flap is readily visible. The authors also review the anticoagulants used and a postoperative flap monitoring protocol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19952698     DOI: 10.1097/PRS.0b013e3181bcf07b

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  11 in total

1.  Postoperative monitoring of free flap reconstruction: A comparison of external Doppler ultrasonography and the implantable Doppler probe.

Authors:  Rayaad C Hosein; Agustin Cornejo; Howard T Wang
Journal:  Plast Surg (Oakv)       Date:  2016       Impact factor: 0.947

Review 2.  Free Tissue Breast Reconstruction.

Authors:  Rami Dibbs; Jeff Trost; Valerie DeGregorio; Shayan Izaddoost
Journal:  Semin Plast Surg       Date:  2019-03-08       Impact factor: 2.314

Review 3.  Unfavourable results in free tissue transfer.

Authors:  Ashok Raj Koul; Rahul K Patil; Sushil Nahar
Journal:  Indian J Plast Surg       Date:  2013-05

4.  Outcomes Comparison for Microsurgical Breast Reconstruction in Specialty Surgery Hospitals Versus Tertiary Care Facilities.

Authors:  Rahul Vemula; Matthew J Bartow; Matt Freeman; Cameron Callaghan; Tim Matatov; David Jansen; Bob Allen; Hugo St Hilaire; Oren Tessler
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-10-10

5.  Impact of Periosteal Branches and Septo-Cutaneous Perforators on Free Fibula Flap Outcome: A Retrospective Analysis of Computed Tomography Angiography Scans in Virtual Surgical Planning.

Authors:  Michael Knitschke; Anna Katrin Baumgart; Christina Bäcker; Christian Adelung; Fritz Roller; Daniel Schmermund; Sebastian Böttger; Philipp Streckbein; Hans-Peter Howaldt; Sameh Attia
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

6.  Macrophage Migration Inhibitory Factor-An Innovative Indicator for Free Flap Ischemia after Microsurgical Reconstruction.

Authors:  Ioannis-Fivos Megas; David Simons; Bong-Sung Kim; Christian Stoppe; Andrzej Piatkowski; Panagiotis Fikatas; Paul Christian Fuchs; Jacqueline Bastiaanse; Norbert Pallua; Jürgen Bernhagen; Gerrit Grieb
Journal:  Healthcare (Basel)       Date:  2021-05-21

7.  Microvascular free-flap transfer for head and neck reconstruction in elderly patients.

Authors:  Francesco Turrà; Simone La Padula; Sergio Razzano; Paola Bonavolontà; Gisella Nele; Sergio Marlino; Luigi Canta; Pasquale Graziano; Giovanni Dell'Aversana Orabona; Fabrizio Schonauer
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

8.  My first 100 consecutive microvascular free flaps: pearls and lessons learned in first year of practice.

Authors:  Edward I Chang
Journal:  Plast Reconstr Surg Glob Open       Date:  2013-08-07

9.  Assessment of perfusion of free flaps used in head and neck reconstruction using pulsatility index.

Authors:  Akshay Kapoor; Malay Karmakar; Collin Roy; Kaushal Priya Anand
Journal:  Indian J Plast Surg       Date:  2017 May-Aug

10.  Anterograde injection of low-dose urokinase salvages free anterolateral thigh flap: A case report of safe and effective treatment.

Authors:  Shao-Yun Hsu; Hsu-Tang Cheng; Oscar Manrique; Yung-Chang Hsu
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.